Systems-level immunomonitoring from acute to recovery phase of severe COVID-19

Published: 24 June 2021| Version 1 | DOI: 10.17632/734559nz2k.1
Lucie Rodriguez


Olink and raw mass cytometry data from longitudinal samples of symptomatic patients with positive SARS-CoV-2 PCR test admitted to Helsinki University Hospital, Helsinki Finland. The study includes 37 adults patients diagnosed with COVID-19 with blood samples from acute to recovery phases of the disease.